ICASA aims to contribute to a substantial decrease in the proportion of ADHD patients developing an addiction/substance use disorder (SUD) and to substantially improve the detection, diagnosis and treatment of patients having both ADHD and SUD.

Highlights on website

Selected evidence

A collection of relevant literature regarding the topic of ADHD and Substance abuse disorder comborbidity. Regularly updated to present the most recent scientific insights.


Latest news

European Addiction Research released the Special Topic Issue on ADHD-Addiction (Vol. 26, No. 4-5, 2020). You will find an editorial, a review on history and future of ICASA projects, the consensus statement on ADHD-Addiction in adolescents, a review on Continuous Performance Tests for diagnosing ADHD in Substance Use Disorders patients, and ten new research articles on ADHD-Addiction. Please visit: https://www.karger.com/Journal/Issue/279180.

ICASA Research

Stakeholders of ICASA


If you are a member: find all the information about our network on this website: inclusion of subjects in the incas study, upcoming icasa meetings, events etcetera. If you consider to participate: look around and contact us.

Treatment providers

If you are working as a treatment provider in the field of ADHD, general psychiatry and/or addiction, you may work with patients suffering from Substance Use Disorders comorbidity. Keep your knowledge up to date with the latest insights gathered on one website.

world map

Contact details of ICASA